197 related articles for article (PubMed ID: 24212892)
1. The active identification and management of chronic refractory breathlessness is a human right.
Currow DC; Abernethy AP; Ko DN
Thorax; 2014 Apr; 69(4):393-4. PubMed ID: 24212892
[TBL] [Abstract][Full Text] [Related]
2. Management of acute breathlessness in the person with chronic refractory breathlessness.
Donesky D
Curr Opin Support Palliat Care; 2015 Sep; 9(3):212-6. PubMed ID: 26147913
[TBL] [Abstract][Full Text] [Related]
3. Managing chronic breathlessness in the community.
Duncan D; Ashby A
Br J Community Nurs; 2018 Jul; 23(7):318-321. PubMed ID: 29972663
[TBL] [Abstract][Full Text] [Related]
4. Chronic refractory dyspnoea--evidence based management.
Wiseman R; Rowett D; Allcroft P; Abernethy A; Currow DC
Aust Fam Physician; 2013 Mar; 42(3):137-40. PubMed ID: 23529525
[TBL] [Abstract][Full Text] [Related]
5. The role of airflow for the relief of chronic refractory breathlessness.
Swan F; Booth S
Curr Opin Support Palliat Care; 2015 Sep; 9(3):206-11. PubMed ID: 26262829
[TBL] [Abstract][Full Text] [Related]
6. Breathlessness--current and emerging mechanisms, measurement and management: a discussion from an European Association of Palliative Care workshop.
Currow DC; Higginson IJ; Johnson MJ
Palliat Med; 2013 Dec; 27(10):932-8. PubMed ID: 23838379
[TBL] [Abstract][Full Text] [Related]
7. [Management of refractory dyspnoea in patients with advanced diseases - evidence-based update for clinical practice].
Simon ST; Altfelder N; Voltz R; Gaertner J
Ther Umsch; 2012 Feb; 69(2):93-7. PubMed ID: 22334199
[TBL] [Abstract][Full Text] [Related]
8. A community population survey of prevalence and severity of dyspnea in adults.
Currow DC; Plummer JL; Crockett A; Abernethy AP
J Pain Symptom Manage; 2009 Oct; 38(4):533-45. PubMed ID: 19822276
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and assessment of breathlessness in the clinical setting.
Johnson MJ; Currow DC; Booth S
Expert Rev Respir Med; 2014 Apr; 8(2):151-61. PubMed ID: 24450289
[TBL] [Abstract][Full Text] [Related]
10. [Symptomatic relief in dyspnoea].
Jespersen BA; Salomonsen A; Rasmussen TR
Ugeskr Laeger; 2007 Oct; 169(44):3756-9. PubMed ID: 18028843
[TBL] [Abstract][Full Text] [Related]
11. Opioids for chronic refractory breathlessness: patient predictors of beneficial response.
Johnson MJ; Bland JM; Oxberry SG; Abernethy AP; Currow DC
Eur Respir J; 2013 Sep; 42(3):758-66. PubMed ID: 23258776
[TBL] [Abstract][Full Text] [Related]
12. Causes and management of chronic breathlessness in adults.
Booker R
Nurs Times; 2004 Sep 21-27; 100(38):46-7, 49-50. PubMed ID: 15493766
[TBL] [Abstract][Full Text] [Related]
13. Does palliative home oxygen improve dyspnoea? A consecutive cohort study.
Currow DC; Agar M; Smith J; Abernethy AP
Palliat Med; 2009 Jun; 23(4):309-16. PubMed ID: 19304806
[TBL] [Abstract][Full Text] [Related]
14. Opioids for chronic refractory breathlessness: right patient, right route?
Currow DC; Ekstrom M; Abernethy AP
Drugs; 2014 Jan; 74(1):1-6. PubMed ID: 24327297
[TBL] [Abstract][Full Text] [Related]
15. Measurement of dyspnoea in the clinical rather than the research setting.
Bausewein C; Booth S; Higginson IJ
Curr Opin Support Palliat Care; 2008 Jun; 2(2):95-9. PubMed ID: 18685403
[TBL] [Abstract][Full Text] [Related]
16. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
17. Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study.
Currow DC; Smith J; Davidson PM; Newton PJ; Agar MR; Abernethy AP
J Pain Symptom Manage; 2010 Apr; 39(4):680-90. PubMed ID: 20413056
[TBL] [Abstract][Full Text] [Related]
18. Clinically important differences in the intensity of chronic refractory breathlessness.
Johnson MJ; Bland JM; Oxberry SG; Abernethy AP; Currow DC
J Pain Symptom Manage; 2013 Dec; 46(6):957-63. PubMed ID: 23608121
[TBL] [Abstract][Full Text] [Related]
19. Assessment and management of refractory breathlessness in interstitial lung disease.
Speakman L; Walthall H
Br J Community Nurs; 2017 Sep; 22(9):434-439. PubMed ID: 28862913
[TBL] [Abstract][Full Text] [Related]
20. Episodes of breathlessness: types and patterns - a qualitative study exploring experiences of patients with advanced diseases.
Simon ST; Higginson IJ; Benalia H; Gysels M; Murtagh FE; Spicer J; Bausewein C
Palliat Med; 2013 Jun; 27(6):524-32. PubMed ID: 23486931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
